Finch Therapeutics Group, Inc.

OTCPK:FNCH Stock Report

Market Cap: US$19.2m

Finch Therapeutics Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:FNCH Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Mar 24SellUS$21,246Jeffery SmisekIndividual8,242US$2.61
22 Nov 23SellUS$5,351Jeffery SmisekIndividual1,470US$3.64

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FNCH?
Owner TypeNumber of SharesOwnership Percentage
Institutions21,2071.32%
Individual Insiders709,74044.2%
General Public874,81654.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 9 shareholders own 45.52% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
26.2%
Chris Shumway
421,381US$5.0m0%no data
9.99%
Chidozie Ugwumba
160,366US$1.9m0%no data
3.95%
Mark Smith
63,434US$759.6k0%no data
2.63%
Jeffery Smisek
42,253US$506.0k549%no data
1.32%
Domenic Ferrante
21,206US$253.9k0%no data
1.32%
Lake Street Advisors, LLC
21,206US$253.9k0%0.01%
0.058%
Marc Blaustein
933US$11.2k0%no data
0.01%
Susan Graf
167US$2.0k0%no data
0.00006%
Guggenheim Partners, LLC
1US$11.50%no data